Weight | 529.526 g/mol |
---|---|
Formula | C28H22F3N7O |
Hydrogen Acceptors | 7 |
Hydrogen Donors | 2 |
Aromatic Rings | 5 |
Rotatable Bonds | 6 |
Nilotinib (641571-10-0)

"What do you need help with?"

LabBot
- Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome-Positive ALL (The New England Journal of Medicine, 2006)
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia (The New England Journal of Medicine, 2010)
- Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance (Blood, 2007)
- Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets (Blood, 2007)
- OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib. (Blood, 2006)
- Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)based mutagenesis screen: high efficacy of drug combinations (Blood, 2006)
-
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. -
SMILESCC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5
-
InChIKeyHHZIURLSWUIHRB-UHFFFAOYSA-N
- Pubchem - Nilotinib
- Wikipedia - nilotinib
Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. Structurally related to imatinib, it was developed based on the structure of the Abl-imatinib complex to address imatinib intolerance and resistance. Nilotinib is a selective Bcr-Abl kinase inhibitor that is 1030 fold more potent than imatinib in inhibiting Bcr-Abl tyrosine kinase activity and proliferation of Bcr-Abl expressing cells.
Suppliers
Most-cited Publications
Areas of Application
Safety
Alternate Names
External Links
Similar Compounds
Imatinib mesylate
(220127-57-1)
1 alternate name
3 suppliers
thiostrepton
(1393-48-2)
1 alternate name
3 suppliers
7-amino-AMD
(7240-37-1)
1 alternate name
3 suppliers
Chetomin
(1403-36-7)
1 alternate name
3 suppliers
Bleomycin sulfate
(11056-06-7, 9041-93-4)
1 alternate name
3 suppliers
Leurosidine sulfate
(18556-44-0)
1 alternate name
3 suppliers
ATORVASTATIN CALCIUM
(110862-48-1, 134523-03-8)
1 alternate name
3 suppliers
Cyanocobalamine
(68-19-9)
1 alternate name
3 suppliers
vitamin B12
(13408-78-1, 68-19-9)
1 alternate name
3 suppliers
Cyanokit
(13422-51-0)
1 alternate name
3 suppliers
IRINOTECAN HYDROCHLORIDE Trihydrate
(136572-09-3)
1 alternate name
3 suppliers
TOPOTECAN HYDROCHLORIDE
(119413-54-6)
1 alternate name
3 suppliers
Rubitecan
(91421-42-0)
1 alternate name
3 suppliers
penitrem A
(12627-35-9)
1 alternate name
3 suppliers
Pirenzepine dihydrochloride
(29868-97-1)
1 alternate name
3 suppliers
Rifamycin S
(13553-79-2)
1 alternate name
3 suppliers
Brucine hydrochloride
(5786-96-9)
1 alternate name
3 suppliers
126643-37-6
(126643-37-6)
1 alternate name
3 suppliers
Fendosal
(53597-27-6)
1 alternate name
3 suppliers
28797-48-0
(28797-48-0)
1 alternate name
3 suppliers
69898-40-4
(69898-40-4)
1 alternate name
3 suppliers
Tezosentan
(180384-57-0)
1 alternate name
3 suppliers
vineomycin a1
(78164-00-8)
1 alternate name
3 suppliers
429658-95-7
(429658-95-7)
1 alternate name
3 suppliers
10-Deacetyltaxol
(78432-77-6, 111149-94-1)
1 alternate name
3 suppliers
sulforhodamine 101
(60311-02-6)
1 alternate name
3 suppliers
104960-56-7
(104960-56-7)
1 alternate name
3 suppliers
BETA-AMANITIN
(21150-22-1)
1 alternate name
3 suppliers
Calcium levofolinate
(80433-71-2, 1492-18-8)
1 alternate name
3 suppliers
UNII-U3L0HCE5OI
(6885-57-0)
1 alternate name
3 suppliers
Puromycin hydrochloride
(58-58-2)
1 alternate name
3 suppliers
AFLATOXIN G1
(1165-39-5)
1 alternate name
3 suppliers
UNII-1ZCR3Z51KV
(24292-60-2)
1 alternate name
3 suppliers
NADP (sodium salt)
(1184-16-3)
1 alternate name
3 suppliers
11J-560S
(62522-87-6)
1 alternate name
3 suppliers
AFLATOXIN G2
(7241-98-7)
1 alternate name
3 suppliers
159885-63-9
(159885-63-9)
1 alternate name
3 suppliers
Nadph tetrasodium salt
(2646-71-1)
1 alternate name
3 suppliers
5-Naphthalen-2-yl-7-trifluoromethyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid ethyl ester
(679830-65-0)
1 alternate name
3 suppliers
96323-20-5
(96323-20-5)
1 alternate name
3 suppliers
Oxacillin sodium hydrate
(1173-88-2, 7240-38-2)
1 alternate name
3 suppliers
Aflatoxin B1
(1162-65-8)
1 alternate name
3 suppliers
31188-91-7
(31188-91-7)
1 alternate name
3 suppliers
Olmesartan medoxomil
(144689-63-4)
1 alternate name
3 suppliers
1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid
(159885-82-2)
1 alternate name
3 suppliers
Lestaurtinib
(111358-88-4)
1 alternate name
3 suppliers
Ulifloxacin
(112984-60-8)
1 alternate name
3 suppliers
Reactive Orange 14
(12225-86-4)
1 alternate name
3 suppliers
Candesartan cilexetil
(145040-37-5)
1 alternate name
3 suppliers
coelenterazine
(55779-48-1)
1 alternate name
3 suppliers
Doxorubicin Hydrochloride
(25316-40-9)
1 alternate name
3 suppliers
AC1L4AIM
(73069-23-5)
1 alternate name
3 suppliers
AFLATOXIN B2
(7220-81-7)
1 alternate name
3 suppliers
CEFOTAXIME SODIUM
(64485-93-4)
1 alternate name
3 suppliers
ethyl 1-(4-phenyl-1,3-thiazol-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate
(159885-61-7)
1 alternate name
3 suppliers
NADH (disodium salt)
(606-68-8)
1 alternate name
3 suppliers
4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
(10298-40-5)
1 alternate name
3 suppliers
Indolo[2,1-b]quinazoline-6,12-dione
(13220-57-0)
1 alternate name
3 suppliers
Aflatoxin Ro
(30419-23-9, 29611-03-8)
1 alternate name
3 suppliers
100491-29-0
(100491-29-0)
1 alternate name
1 safety hazard
3 suppliers
ethyl 2-chloro-3-cyano-6-methyl-5-nitroisonicotinate
(72701-63-4)
1 alternate name
3 suppliers
3-acetylpyridine adenine dinucleotide
(86-08-8)
1 alternate name
3 suppliers
Sand-PR
(112820-42-5)
1 alternate name
3 suppliers
Marbofloxacin
(115550-35-1)
1 alternate name
3 suppliers
885-70-1
(885-70-1)
1 alternate name
3 suppliers
CEFOPERAZONE SODIUM
(62893-20-3)
1 alternate name
3 suppliers
Fluazuron
(86811-58-7)
1 alternate name
3 suppliers
PHALLOIDIN
(17466-45-4)
1 alternate name
3 suppliers
Difloxacin
(98106-17-3)
1 alternate name
3 suppliers
Diflufenican
(83164-33-4)
1 alternate name
1 safety hazard
3 suppliers
Coenzyme A, trilithium salt
(18439-24-2)
1 alternate name
3 suppliers
SARAFLOXACIN HYDROCHLORIDE
(91296-87-6)
1 alternate name
3 suppliers
315703-52-7
(315703-52-7)
1 alternate name
3 suppliers
Lomefloxacin hydrochloride
(98079-52-8)
1 alternate name
3 suppliers
20749-68-2
(74738-71-9, 20749-68-2)
1 alternate name
3 suppliers
CAS Directory